

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.73746604 |
| 2 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.44709086 |
| 3 | vocalization behavior (GO:0071625) | 5.43560260 |
| 4 | glutamate receptor signaling pathway (GO:0007215) | 5.30846441 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.30639083 |
| 6 | behavioral response to nicotine (GO:0035095) | 5.19939615 |
| 7 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.11744312 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.11014777 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.02343422 |
| 10 | neuronal action potential propagation (GO:0019227) | 4.95810677 |
| 11 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.81122639 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.78259406 |
| 13 | response to pheromone (GO:0019236) | 4.76540117 |
| 14 | synaptic transmission, glutamatergic (GO:0035249) | 4.74012731 |
| 15 | cerebellar granule cell differentiation (GO:0021707) | 4.73606904 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.69882244 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 4.61768845 |
| 18 | positive regulation of synapse maturation (GO:0090129) | 4.60943287 |
| 19 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.56759187 |
| 20 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.51653639 |
| 21 | glutamate secretion (GO:0014047) | 4.48819399 |
| 22 | protein localization to synapse (GO:0035418) | 4.48414609 |
| 23 | cellular potassium ion homeostasis (GO:0030007) | 4.40017034 |
| 24 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.38596327 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 4.37012142 |
| 26 | synaptic vesicle maturation (GO:0016188) | 4.35470353 |
| 27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.30934765 |
| 28 | neurotransmitter secretion (GO:0007269) | 4.29910627 |
| 29 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.25607681 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.19401873 |
| 31 | long-term memory (GO:0007616) | 4.16980166 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.16928023 |
| 33 | nucleobase catabolic process (GO:0046113) | 4.08819182 |
| 34 | gamma-aminobutyric acid transport (GO:0015812) | 4.07400452 |
| 35 | regulation of synaptic vesicle transport (GO:1902803) | 4.00238481 |
| 36 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.99203649 |
| 37 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.95908973 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.89426465 |
| 39 | layer formation in cerebral cortex (GO:0021819) | 3.87991906 |
| 40 | exploration behavior (GO:0035640) | 3.86746176 |
| 41 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.86181832 |
| 42 | regulation of postsynaptic membrane potential (GO:0060078) | 3.85308439 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.85198711 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.84377657 |
| 45 | axonal fasciculation (GO:0007413) | 3.82291606 |
| 46 | neuron recognition (GO:0008038) | 3.78573491 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.77204317 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75655033 |
| 49 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.72200492 |
| 50 | cell differentiation in hindbrain (GO:0021533) | 3.70398844 |
| 51 | regulation of synapse maturation (GO:0090128) | 3.69655746 |
| 52 | regulation of synapse structural plasticity (GO:0051823) | 3.64460054 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.62179654 |
| 54 | sodium ion export (GO:0071436) | 3.61676790 |
| 55 | dendritic spine morphogenesis (GO:0060997) | 3.61596921 |
| 56 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.61124813 |
| 57 | regulation of neurotransmitter secretion (GO:0046928) | 3.61055980 |
| 58 | innervation (GO:0060384) | 3.59560458 |
| 59 | membrane depolarization during action potential (GO:0086010) | 3.56260236 |
| 60 | dendrite morphogenesis (GO:0048813) | 3.56242159 |
| 61 | neurotransmitter transport (GO:0006836) | 3.55634989 |
| 62 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.54113724 |
| 63 | postsynaptic membrane organization (GO:0001941) | 3.52941918 |
| 64 | startle response (GO:0001964) | 3.51586954 |
| 65 | positive regulation of membrane potential (GO:0045838) | 3.51109668 |
| 66 | membrane hyperpolarization (GO:0060081) | 3.47813641 |
| 67 | auditory behavior (GO:0031223) | 3.45388655 |
| 68 | membrane depolarization (GO:0051899) | 3.41567936 |
| 69 | behavioral response to ethanol (GO:0048149) | 3.41546098 |
| 70 | neuronal action potential (GO:0019228) | 3.39388296 |
| 71 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.38659843 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.31809065 |
| 73 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.29502335 |
| 74 | cell migration in hindbrain (GO:0021535) | 3.27711926 |
| 75 | regulation of neurotransmitter transport (GO:0051588) | 3.26065451 |
| 76 | regulation of vesicle fusion (GO:0031338) | 3.25693887 |
| 77 | synapse assembly (GO:0007416) | 3.25533274 |
| 78 | positive regulation of synapse assembly (GO:0051965) | 3.25485956 |
| 79 | retinal ganglion cell axon guidance (GO:0031290) | 3.24617612 |
| 80 | negative regulation of dendrite development (GO:2000171) | 3.24597453 |
| 81 | prepulse inhibition (GO:0060134) | 3.22729420 |
| 82 | regulation of neurotransmitter levels (GO:0001505) | 3.22198417 |
| 83 | cochlea development (GO:0090102) | 3.21740648 |
| 84 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.21705469 |
| 85 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.20353125 |
| 86 | behavioral defense response (GO:0002209) | 3.20187872 |
| 87 | behavioral fear response (GO:0001662) | 3.20187872 |
| 88 | regulation of synaptic plasticity (GO:0048167) | 3.19224937 |
| 89 | learning (GO:0007612) | 3.19212518 |
| 90 | neuromuscular process controlling posture (GO:0050884) | 3.18609285 |
| 91 | serotonin metabolic process (GO:0042428) | 3.18214297 |
| 92 | mechanosensory behavior (GO:0007638) | 3.17090749 |
| 93 | regulation of action potential (GO:0098900) | 3.15979484 |
| 94 | establishment of mitochondrion localization (GO:0051654) | 3.11948113 |
| 95 | protein polyglutamylation (GO:0018095) | 3.11471139 |
| 96 | proline transport (GO:0015824) | 3.10694783 |
| 97 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.10551248 |
| 98 | fear response (GO:0042596) | 3.09360441 |
| 99 | presynaptic membrane organization (GO:0097090) | 3.08575577 |
| 100 | adult walking behavior (GO:0007628) | 3.06721212 |
| 101 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.06587479 |
| 102 | response to auditory stimulus (GO:0010996) | 3.06287413 |
| 103 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.04812421 |
| 104 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.04776381 |
| 105 | response to histamine (GO:0034776) | 3.04650372 |
| 106 | synaptic transmission, cholinergic (GO:0007271) | 3.04597900 |
| 107 | axon ensheathment in central nervous system (GO:0032291) | 3.04161090 |
| 108 | central nervous system myelination (GO:0022010) | 3.04161090 |
| 109 | primary amino compound metabolic process (GO:1901160) | 3.04139457 |
| 110 | presynaptic membrane assembly (GO:0097105) | 3.03990553 |
| 111 | cell communication by electrical coupling (GO:0010644) | 3.02755247 |
| 112 | synaptic transmission (GO:0007268) | 3.02033041 |
| 113 | positive regulation of dendritic spine development (GO:0060999) | 3.00486889 |
| 114 | central nervous system neuron axonogenesis (GO:0021955) | 3.00000025 |
| 115 | potassium ion homeostasis (GO:0055075) | 2.95937965 |
| 116 | establishment of nucleus localization (GO:0040023) | 2.93671688 |
| 117 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.93533890 |
| 118 | neuromuscular synaptic transmission (GO:0007274) | 2.93022830 |
| 119 | synapse organization (GO:0050808) | 2.92353840 |
| 120 | mating behavior (GO:0007617) | 2.90959775 |
| 121 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.79497044 |
| 122 | spinal cord development (GO:0021510) | 2.77042731 |
| 123 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.71913195 |
| 124 | mitochondrion transport along microtubule (GO:0047497) | 2.71913195 |
| 125 | limb bud formation (GO:0060174) | 2.69515277 |
| 126 | neural tube formation (GO:0001841) | 2.69284854 |
| 127 | adult behavior (GO:0030534) | 2.67925562 |
| 128 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.67469007 |
| 129 | action potential (GO:0001508) | 2.67106272 |
| 130 | L-fucose catabolic process (GO:0042355) | 2.65218481 |
| 131 | fucose catabolic process (GO:0019317) | 2.65218481 |
| 132 | L-fucose metabolic process (GO:0042354) | 2.65218481 |
| 133 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.62211447 |
| 134 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.61720064 |
| 135 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.61021023 |
| 136 | negative regulation of axon extension (GO:0030517) | 2.60456353 |
| 137 | retinal cone cell development (GO:0046549) | 2.59305713 |
| 138 | glycosphingolipid biosynthetic process (GO:0006688) | 2.57345139 |
| 139 | regulation of neurotransmitter uptake (GO:0051580) | 2.55341025 |
| 140 | response to amphetamine (GO:0001975) | 2.54187911 |
| 141 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.53314805 |
| 142 | neuronal ion channel clustering (GO:0045161) | 2.52659648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.88761030 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.83143516 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03044415 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.01859081 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99787266 |
| 6 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.69156531 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.67863457 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.57144643 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.57144643 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55565290 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.54493893 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.52379541 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.51087661 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.43984497 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43711251 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39532299 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35216066 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29842719 |
| 19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.26155487 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19187352 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17290893 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.13917031 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.12740472 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01987578 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.95301161 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.91969590 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.89781157 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.88062860 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.87419840 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87389671 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86843470 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.80118721 |
| 33 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.79770672 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77360277 |
| 35 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75985056 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.72501355 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.68722255 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.68564804 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61616990 |
| 40 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56403104 |
| 41 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55506100 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52886889 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.52422439 |
| 44 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.51735392 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44199070 |
| 46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.42016349 |
| 47 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41154403 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41065554 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.40924240 |
| 50 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40812233 |
| 51 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.40526940 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40217022 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39983188 |
| 54 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37912941 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35786149 |
| 56 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.34732804 |
| 57 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.34732804 |
| 58 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.34706038 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34612244 |
| 60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.34395150 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33685485 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.32939801 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31535092 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.29742932 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27645955 |
| 66 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27206206 |
| 67 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26575089 |
| 68 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.25261948 |
| 69 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24319398 |
| 70 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.23602984 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22562692 |
| 72 | AR_19668381_ChIP-Seq_PC3_Human | 1.21989595 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20143834 |
| 74 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19168531 |
| 75 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.19168531 |
| 76 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19081661 |
| 77 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17913017 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17409571 |
| 79 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.16275518 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15809581 |
| 81 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14319515 |
| 82 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13994302 |
| 83 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.13810768 |
| 84 | TP53_16413492_ChIP-PET_HCT116_Human | 1.13683977 |
| 85 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13583127 |
| 86 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11755914 |
| 87 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11202393 |
| 88 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09943571 |
| 89 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09748240 |
| 90 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09189744 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.09076948 |
| 92 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08666720 |
| 93 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07752329 |
| 94 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.07112735 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06927076 |
| 96 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06890916 |
| 97 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06789452 |
| 98 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05878922 |
| 99 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05716761 |
| 100 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.05592571 |
| 101 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.05438235 |
| 102 | * JUN_21703547_ChIP-Seq_K562_Human | 1.04243764 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03908660 |
| 104 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03900332 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03829847 |
| 106 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01840138 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01641439 |
| 108 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00827685 |
| 109 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00449088 |
| 110 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00149411 |
| 111 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99887898 |
| 112 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.99350902 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98369029 |
| 114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95479138 |
| 115 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95173885 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.94273831 |
| 117 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94244557 |
| 118 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94138604 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93160881 |
| 120 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92832436 |
| 121 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.92768668 |
| 122 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91572303 |
| 123 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.89229581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.52712006 |
| 2 | MP0003880_abnormal_central_pattern | 4.15733452 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.04613698 |
| 4 | MP0009046_muscle_twitch | 3.75685590 |
| 5 | MP0004270_analgesia | 3.34366625 |
| 6 | MP0009745_abnormal_behavioral_response | 3.30925041 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.21038011 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.08553320 |
| 9 | MP0002064_seizures | 3.05815994 |
| 10 | MP0002272_abnormal_nervous_system | 2.87102688 |
| 11 | * MP0002572_abnormal_emotion/affect_behav | 2.83232925 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.73074319 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.68698197 |
| 14 | MP0001486_abnormal_startle_reflex | 2.59992087 |
| 15 | MP0002736_abnormal_nociception_after | 2.57390006 |
| 16 | MP0001984_abnormal_olfaction | 2.44522150 |
| 17 | MP0002184_abnormal_innervation | 2.39829642 |
| 18 | MP0002067_abnormal_sensory_capabilities | 2.38014427 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.34114845 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.32738182 |
| 21 | MP0000778_abnormal_nervous_system | 2.25408234 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.24345889 |
| 23 | MP0008569_lethality_at_weaning | 2.19570539 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.88348116 |
| 25 | MP0002557_abnormal_social/conspecific_i | 1.85539937 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.84353506 |
| 27 | MP0001970_abnormal_pain_threshold | 1.81037601 |
| 28 | MP0004858_abnormal_nervous_system | 1.77416921 |
| 29 | MP0001188_hyperpigmentation | 1.76475363 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.75363104 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.70735084 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.68603846 |
| 33 | MP0004924_abnormal_behavior | 1.64456645 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.64456645 |
| 35 | MP0000955_abnormal_spinal_cord | 1.60654322 |
| 36 | MP0004133_heterotaxia | 1.58774862 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.58566888 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.54717124 |
| 39 | MP0003787_abnormal_imprinting | 1.52530105 |
| 40 | MP0005551_abnormal_eye_electrophysiolog | 1.52087684 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.51242123 |
| 42 | MP0004142_abnormal_muscle_tone | 1.48104178 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.47598092 |
| 44 | MP0004742_abnormal_vestibular_system | 1.43580423 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.40902155 |
| 46 | MP0003890_abnormal_embryonic-extraembry | 1.40759681 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.36658772 |
| 48 | MP0003121_genomic_imprinting | 1.28617706 |
| 49 | MP0003879_abnormal_hair_cell | 1.27544143 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.27499662 |
| 51 | MP0003329_amyloid_beta_deposits | 1.26991153 |
| 52 | MP0003136_yellow_coat_color | 1.25411565 |
| 53 | MP0004885_abnormal_endolymph | 1.24423510 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.23203406 |
| 55 | MP0004043_abnormal_pH_regulation | 1.22843130 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.19499676 |
| 57 | MP0002152_abnormal_brain_morphology | 1.19400872 |
| 58 | MP0003122_maternal_imprinting | 1.16570772 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.16139897 |
| 60 | MP0003633_abnormal_nervous_system | 1.13618965 |
| 61 | MP0003632_abnormal_nervous_system | 1.11901708 |
| 62 | MP0002909_abnormal_adrenal_gland | 1.11352843 |
| 63 | MP0003631_nervous_system_phenotype | 1.10753970 |
| 64 | MP0004215_abnormal_myocardial_fiber | 1.08581059 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.07864005 |
| 66 | MP0005499_abnormal_olfactory_system | 1.07527736 |
| 67 | MP0005394_taste/olfaction_phenotype | 1.07527736 |
| 68 | MP0002837_dystrophic_cardiac_calcinosis | 1.01700249 |
| 69 | MP0003195_calcinosis | 1.01304877 |
| 70 | MP0002752_abnormal_somatic_nervous | 1.00639331 |
| 71 | MP0001177_atelectasis | 0.99567668 |
| 72 | MP0005195_abnormal_posterior_eye | 0.96231718 |
| 73 | MP0001529_abnormal_vocalization | 0.95233166 |
| 74 | MP0005187_abnormal_penis_morphology | 0.94106520 |
| 75 | MP0002229_neurodegeneration | 0.92594647 |
| 76 | MP0002938_white_spotting | 0.92154179 |
| 77 | MP0006292_abnormal_olfactory_placode | 0.91576805 |
| 78 | MP0000751_myopathy | 0.90944204 |
| 79 | MP0000427_abnormal_hair_cycle | 0.90598860 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 0.89887589 |
| 81 | MP0005171_absent_coat_pigmentation | 0.87749648 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.87529677 |
| 83 | MP0003119_abnormal_digestive_system | 0.86491766 |
| 84 | MP0002822_catalepsy | 0.85925311 |
| 85 | MP0001299_abnormal_eye_distance/ | 0.85632183 |
| 86 | MP0001905_abnormal_dopamine_level | 0.85551282 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.83698977 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.83478223 |
| 89 | MP0004085_abnormal_heartbeat | 0.82402363 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.81812560 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 0.81501918 |
| 92 | MP0002102_abnormal_ear_morphology | 0.81457233 |
| 93 | MP0008872_abnormal_physiological_respon | 0.80451555 |
| 94 | MP0005253_abnormal_eye_physiology | 0.79019419 |
| 95 | MP0000647_abnormal_sebaceous_gland | 0.78140020 |
| 96 | MP0001919_abnormal_reproductive_system | 0.77571660 |
| 97 | MP0003861_abnormal_nervous_system | 0.77335448 |
| 98 | MP0002090_abnormal_vision | 0.76872340 |
| 99 | MP0002876_abnormal_thyroid_physiology | 0.76457152 |
| 100 | MP0004484_altered_response_of | 0.75152200 |
| 101 | MP0000372_irregular_coat_pigmentation | 0.74673622 |
| 102 | MP0003634_abnormal_glial_cell | 0.74635207 |
| 103 | MP0003938_abnormal_ear_development | 0.73919897 |
| 104 | MP0005409_darkened_coat_color | 0.71658653 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.69967565 |
| 106 | MP0000566_synostosis | 0.69582862 |
| 107 | MP0005174_abnormal_tail_pigmentation | 0.68696319 |
| 108 | MP0008875_abnormal_xenobiotic_pharmacok | 0.68497525 |
| 109 | MP0002928_abnormal_bile_duct | 0.67103691 |
| 110 | MP0000026_abnormal_inner_ear | 0.66924520 |
| 111 | MP0000920_abnormal_myelination | 0.66813440 |
| 112 | MP0003698_abnormal_male_reproductive | 0.66493557 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.64116302 |
| 114 | MP0001943_abnormal_respiration | 0.61157492 |
| 115 | MP0010769_abnormal_survival | 0.60340106 |
| 116 | MP0008874_decreased_physiological_sensi | 0.60070981 |
| 117 | MP0010770_preweaning_lethality | 0.59727610 |
| 118 | MP0002082_postnatal_lethality | 0.59727610 |
| 119 | MP0001485_abnormal_pinna_reflex | 0.59289249 |
| 120 | MP0005535_abnormal_body_temperature | 0.58061241 |
| 121 | MP0005623_abnormal_meninges_morphology | 0.57895881 |
| 122 | MP0004147_increased_porphyrin_level | 0.57819921 |
| 123 | MP0010768_mortality/aging | 0.57415506 |
| 124 | MP0004233_abnormal_muscle_weight | 0.56912185 |
| 125 | MP0003045_fibrosis | 0.56596636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.41345479 |
| 2 | Febrile seizures (HP:0002373) | 5.71465005 |
| 3 | Focal seizures (HP:0007359) | 5.69370581 |
| 4 | Progressive cerebellar ataxia (HP:0002073) | 5.61476034 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.26784289 |
| 6 | Atonic seizures (HP:0010819) | 5.17580148 |
| 7 | Action tremor (HP:0002345) | 5.16433693 |
| 8 | Myokymia (HP:0002411) | 5.07713275 |
| 9 | Visual hallucinations (HP:0002367) | 4.91644255 |
| 10 | Absence seizures (HP:0002121) | 4.65989452 |
| 11 | Gaze-evoked nystagmus (HP:0000640) | 4.11921647 |
| 12 | Dialeptic seizures (HP:0011146) | 4.10996795 |
| 13 | Broad-based gait (HP:0002136) | 4.08702080 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.78446948 |
| 15 | Pancreatic cysts (HP:0001737) | 3.75869478 |
| 16 | Hyperventilation (HP:0002883) | 3.64876186 |
| 17 | Pancreatic fibrosis (HP:0100732) | 3.61395779 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.60247491 |
| 19 | True hermaphroditism (HP:0010459) | 3.53550046 |
| 20 | Truncal ataxia (HP:0002078) | 3.44168562 |
| 21 | Genetic anticipation (HP:0003743) | 3.31895311 |
| 22 | Hemiparesis (HP:0001269) | 3.31111184 |
| 23 | Impaired smooth pursuit (HP:0007772) | 3.27483009 |
| 24 | Molar tooth sign on MRI (HP:0002419) | 3.20407647 |
| 25 | Abnormality of midbrain morphology (HP:0002418) | 3.20407647 |
| 26 | Nephronophthisis (HP:0000090) | 3.18636148 |
| 27 | Excessive salivation (HP:0003781) | 3.15290130 |
| 28 | Drooling (HP:0002307) | 3.15290130 |
| 29 | Dysmetria (HP:0001310) | 3.08141457 |
| 30 | Scanning speech (HP:0002168) | 3.02478780 |
| 31 | Diplopia (HP:0000651) | 3.00972100 |
| 32 | Abnormality of binocular vision (HP:0011514) | 3.00972100 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.97698007 |
| 34 | Poor eye contact (HP:0000817) | 2.89130553 |
| 35 | Dysmetric saccades (HP:0000641) | 2.87826071 |
| 36 | Amblyopia (HP:0000646) | 2.87538970 |
| 37 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.87271643 |
| 38 | Lissencephaly (HP:0001339) | 2.86260135 |
| 39 | Limb dystonia (HP:0002451) | 2.78512669 |
| 40 | Abnormal eating behavior (HP:0100738) | 2.70101019 |
| 41 | Epileptiform EEG discharges (HP:0011182) | 2.68712303 |
| 42 | Type II lissencephaly (HP:0007260) | 2.67793587 |
| 43 | Pachygyria (HP:0001302) | 2.66395017 |
| 44 | Depression (HP:0000716) | 2.66335695 |
| 45 | Abnormal social behavior (HP:0012433) | 2.66314592 |
| 46 | Impaired social interactions (HP:0000735) | 2.66314592 |
| 47 | Abnormality of the renal medulla (HP:0100957) | 2.64810439 |
| 48 | Absent speech (HP:0001344) | 2.63208332 |
| 49 | Anxiety (HP:0000739) | 2.60898839 |
| 50 | Abnormality of the renal cortex (HP:0011035) | 2.60865873 |
| 51 | Hemiplegia (HP:0002301) | 2.58356151 |
| 52 | Status epilepticus (HP:0002133) | 2.55413963 |
| 53 | EEG with generalized epileptiform discharges (HP:0011198) | 2.53879064 |
| 54 | Cystic liver disease (HP:0006706) | 2.53505215 |
| 55 | Supranuclear gaze palsy (HP:0000605) | 2.52305601 |
| 56 | Stereotypic behavior (HP:0000733) | 2.45156548 |
| 57 | Optic nerve hypoplasia (HP:0000609) | 2.42667770 |
| 58 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.40562469 |
| 59 | Intention tremor (HP:0002080) | 2.37200425 |
| 60 | Sclerocornea (HP:0000647) | 2.34907407 |
| 61 | Protruding tongue (HP:0010808) | 2.31607144 |
| 62 | Congenital stationary night blindness (HP:0007642) | 2.31033359 |
| 63 | Nephrogenic diabetes insipidus (HP:0009806) | 2.30672004 |
| 64 | Agitation (HP:0000713) | 2.27760609 |
| 65 | Renal cortical cysts (HP:0000803) | 2.25865663 |
| 66 | Hypsarrhythmia (HP:0002521) | 2.25090313 |
| 67 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.24988938 |
| 68 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.24731888 |
| 69 | Fetal akinesia sequence (HP:0001989) | 2.23214700 |
| 70 | Progressive inability to walk (HP:0002505) | 2.22019284 |
| 71 | Anencephaly (HP:0002323) | 2.19418522 |
| 72 | Genital tract atresia (HP:0001827) | 2.18914103 |
| 73 | Horizontal nystagmus (HP:0000666) | 2.16432663 |
| 74 | Abnormality of salivation (HP:0100755) | 2.16246641 |
| 75 | Mutism (HP:0002300) | 2.15288392 |
| 76 | Vaginal atresia (HP:0000148) | 2.13273534 |
| 77 | Tubular atrophy (HP:0000092) | 2.12776641 |
| 78 | Abnormal drinking behavior (HP:0030082) | 2.12201236 |
| 79 | Polydipsia (HP:0001959) | 2.12201236 |
| 80 | Postural instability (HP:0002172) | 2.10641279 |
| 81 | Polyphagia (HP:0002591) | 2.08841150 |
| 82 | Incomplete penetrance (HP:0003829) | 2.08205638 |
| 83 | Blue irides (HP:0000635) | 2.06916705 |
| 84 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04714657 |
| 85 | Chronic hepatic failure (HP:0100626) | 2.04620599 |
| 86 | Aqueductal stenosis (HP:0002410) | 2.01653713 |
| 87 | Esotropia (HP:0000565) | 2.00455350 |
| 88 | Central scotoma (HP:0000603) | 1.99355527 |
| 89 | Inability to walk (HP:0002540) | 1.98054868 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 1.95482114 |
| 91 | Retinal dysplasia (HP:0007973) | 1.94609583 |
| 92 | Volvulus (HP:0002580) | 1.94334375 |
| 93 | Exotropia (HP:0000577) | 1.92060731 |
| 94 | Congenital hepatic fibrosis (HP:0002612) | 1.92055720 |
| 95 | Pendular nystagmus (HP:0012043) | 1.91387244 |
| 96 | Postural tremor (HP:0002174) | 1.91195791 |
| 97 | Abnormality of the lower motor neuron (HP:0002366) | 1.90672125 |
| 98 | Ankle clonus (HP:0011448) | 1.89624289 |
| 99 | Gait ataxia (HP:0002066) | 1.87758697 |
| 100 | Gait imbalance (HP:0002141) | 1.87112581 |
| 101 | Pointed chin (HP:0000307) | 1.86855069 |
| 102 | Abnormality of macular pigmentation (HP:0008002) | 1.86598223 |
| 103 | Hypothermia (HP:0002045) | 1.85826632 |
| 104 | Pheochromocytoma (HP:0002666) | 1.84333272 |
| 105 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.84308937 |
| 106 | Annular pancreas (HP:0001734) | 1.83913150 |
| 107 | Oligodactyly (hands) (HP:0001180) | 1.83594289 |
| 108 | Abnormality of saccadic eye movements (HP:0000570) | 1.82166613 |
| 109 | Attenuation of retinal blood vessels (HP:0007843) | 1.82053462 |
| 110 | Spastic gait (HP:0002064) | 1.81932014 |
| 111 | Intestinal atresia (HP:0011100) | 1.80673754 |
| 112 | Failure to thrive in infancy (HP:0001531) | 1.79930614 |
| 113 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.79755515 |
| 114 | Absent/shortened dynein arms (HP:0200106) | 1.79755515 |
| 115 | Bradykinesia (HP:0002067) | 1.78687351 |
| 116 | Insidious onset (HP:0003587) | 1.78135698 |
| 117 | Termporal pattern (HP:0011008) | 1.78135698 |
| 118 | Decreased central vision (HP:0007663) | 1.77709913 |
| 119 | Postaxial hand polydactyly (HP:0001162) | 1.77695060 |
| 120 | Abnormality of the labia minora (HP:0012880) | 1.77416427 |
| 121 | Papilledema (HP:0001085) | 1.77361367 |
| 122 | Specific learning disability (HP:0001328) | 1.77335278 |
| 123 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.76272953 |
| 124 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.76272953 |
| 125 | Male pseudohermaphroditism (HP:0000037) | 1.76250476 |
| 126 | Narrow forehead (HP:0000341) | 1.75493797 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.75012629 |
| 128 | Abnormal ciliary motility (HP:0012262) | 1.74520947 |
| 129 | Megalencephaly (HP:0001355) | 1.74302309 |
| 130 | Limb ataxia (HP:0002070) | 1.73665952 |
| 131 | Narrow nasal bridge (HP:0000446) | 1.72862451 |
| 132 | Poor coordination (HP:0002370) | 1.72023501 |
| 133 | Hypoventilation (HP:0002791) | 1.71927663 |
| 134 | Furrowed tongue (HP:0000221) | 1.71356525 |
| 135 | Autism (HP:0000717) | 1.71179783 |
| 136 | Impaired vibratory sensation (HP:0002495) | 1.71073409 |
| 137 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.70922923 |
| 138 | Spastic tetraplegia (HP:0002510) | 1.69988360 |
| 139 | Lower limb asymmetry (HP:0100559) | 1.68205109 |
| 140 | Generalized myoclonic seizures (HP:0002123) | 1.68189474 |
| 141 | Postaxial foot polydactyly (HP:0001830) | 1.67283690 |
| 142 | Psychosis (HP:0000709) | 1.67184731 |
| 143 | Inappropriate behavior (HP:0000719) | 1.67116454 |
| 144 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.66604887 |
| 145 | Intellectual disability, severe (HP:0010864) | 1.65454649 |
| 146 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.64346877 |
| 147 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.64216903 |
| 148 | Hypoplasia of the brainstem (HP:0002365) | 1.64216903 |
| 149 | Open mouth (HP:0000194) | 1.62974795 |
| 150 | Poor suck (HP:0002033) | 1.62361443 |
| 151 | Widely spaced teeth (HP:0000687) | 1.62307185 |
| 152 | Abnormal hair whorl (HP:0010721) | 1.61795928 |
| 153 | Neoplasm of the heart (HP:0100544) | 1.59746474 |
| 154 | Cerebral inclusion bodies (HP:0100314) | 1.57716920 |
| 155 | Congenital primary aphakia (HP:0007707) | 1.57212061 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.01771642 |
| 2 | MAP3K4 | 3.20042568 |
| 3 | FRK | 3.19508394 |
| 4 | MAP3K9 | 2.92711815 |
| 5 | MARK1 | 2.89600694 |
| 6 | EPHA4 | 2.83415212 |
| 7 | CASK | 2.78588878 |
| 8 | MINK1 | 2.72309894 |
| 9 | MAP2K7 | 2.70880977 |
| 10 | RIPK4 | 2.38978411 |
| 11 | MAP3K12 | 2.25273279 |
| 12 | TNIK | 2.23445665 |
| 13 | NTRK2 | 2.18499995 |
| 14 | PRPF4B | 2.17917570 |
| 15 | PNCK | 2.11361339 |
| 16 | KSR1 | 2.00259394 |
| 17 | MAP2K4 | 1.95387600 |
| 18 | MAP4K2 | 1.86112340 |
| 19 | BMPR1B | 1.82533615 |
| 20 | DYRK2 | 1.81076137 |
| 21 | CAMKK2 | 1.79609162 |
| 22 | PAK6 | 1.75186445 |
| 23 | DAPK2 | 1.75172231 |
| 24 | TLK1 | 1.65768433 |
| 25 | PLK2 | 1.57579645 |
| 26 | MAPK13 | 1.54532312 |
| 27 | STK38 | 1.49575161 |
| 28 | CAMKK1 | 1.49118727 |
| 29 | GRK1 | 1.49032834 |
| 30 | PRKCG | 1.46645544 |
| 31 | NUAK1 | 1.45944852 |
| 32 | CDK5 | 1.40840910 |
| 33 | SIK2 | 1.35004769 |
| 34 | SGK2 | 1.34737552 |
| 35 | TRIM28 | 1.28720042 |
| 36 | GRK5 | 1.27780919 |
| 37 | KSR2 | 1.25935295 |
| 38 | SGK223 | 1.20817768 |
| 39 | SGK494 | 1.20817768 |
| 40 | DAPK1 | 1.19458418 |
| 41 | CAMK1G | 1.19137449 |
| 42 | BMPR2 | 1.18063209 |
| 43 | WNK4 | 1.17619095 |
| 44 | CDK19 | 1.15108719 |
| 45 | INSRR | 1.11975197 |
| 46 | WNK1 | 1.11207117 |
| 47 | STK39 | 1.09838608 |
| 48 | CAMK2A | 1.08872011 |
| 49 | NTRK1 | 1.04258506 |
| 50 | DYRK1A | 1.03223547 |
| 51 | MKNK2 | 1.01860375 |
| 52 | SIK3 | 0.99086498 |
| 53 | ADRBK2 | 0.98391776 |
| 54 | PTK2B | 0.96821502 |
| 55 | ZAK | 0.93580038 |
| 56 | FES | 0.92686987 |
| 57 | RIPK1 | 0.91871617 |
| 58 | WNK3 | 0.91736008 |
| 59 | CAMK2B | 0.88510846 |
| 60 | CAMK1 | 0.87119266 |
| 61 | SGK3 | 0.85753011 |
| 62 | TAOK3 | 0.85008731 |
| 63 | CSNK1G1 | 0.83661893 |
| 64 | CSNK1G3 | 0.83257464 |
| 65 | NME1 | 0.83175528 |
| 66 | CDK18 | 0.81944145 |
| 67 | STK11 | 0.81911888 |
| 68 | PRKD3 | 0.79708847 |
| 69 | SGK1 | 0.79035495 |
| 70 | CDK15 | 0.77959239 |
| 71 | CSNK1A1L | 0.77942637 |
| 72 | MAPK15 | 0.77514182 |
| 73 | CDK14 | 0.74497253 |
| 74 | PKN1 | 0.74202799 |
| 75 | UHMK1 | 0.73550526 |
| 76 | AKT3 | 0.72742083 |
| 77 | OXSR1 | 0.72392776 |
| 78 | PRKCH | 0.71093751 |
| 79 | BCR | 0.71055328 |
| 80 | TYRO3 | 0.69692927 |
| 81 | PRKCE | 0.69262681 |
| 82 | PHKG1 | 0.69038847 |
| 83 | PHKG2 | 0.69038847 |
| 84 | CAMK2D | 0.68792986 |
| 85 | MAP3K2 | 0.66388931 |
| 86 | ROCK2 | 0.65596776 |
| 87 | CDK11A | 0.65401064 |
| 88 | MAP3K13 | 0.64909789 |
| 89 | RET | 0.64222569 |
| 90 | CDC42BPA | 0.63343318 |
| 91 | FGFR2 | 0.61821090 |
| 92 | TAOK2 | 0.59680533 |
| 93 | ERBB3 | 0.57129990 |
| 94 | CAMK4 | 0.56582427 |
| 95 | DYRK3 | 0.56256454 |
| 96 | NEK6 | 0.56113629 |
| 97 | FGR | 0.55907010 |
| 98 | EPHB2 | 0.55723487 |
| 99 | MARK2 | 0.55403643 |
| 100 | EPHA3 | 0.54748451 |
| 101 | PRKG1 | 0.53879433 |
| 102 | PIK3CA | 0.53607349 |
| 103 | MUSK | 0.53434903 |
| 104 | FER | 0.52969592 |
| 105 | RAF1 | 0.52330503 |
| 106 | RPS6KA3 | 0.51018964 |
| 107 | ACVR1B | 0.48692222 |
| 108 | CSNK1A1 | 0.46996508 |
| 109 | PINK1 | 0.46858062 |
| 110 | CAMK2G | 0.46064871 |
| 111 | VRK1 | 0.45548886 |
| 112 | PRKCB | 0.44412379 |
| 113 | NLK | 0.43996273 |
| 114 | PAK3 | 0.43936883 |
| 115 | FYN | 0.43753968 |
| 116 | PRKACA | 0.43385032 |
| 117 | MAPKAPK5 | 0.42358513 |
| 118 | MAPK10 | 0.42339492 |
| 119 | PRKCZ | 0.41991936 |
| 120 | ARAF | 0.41468597 |
| 121 | CSNK1G2 | 0.40277022 |
| 122 | CDK3 | 0.40033316 |
| 123 | MAP2K6 | 0.39794683 |
| 124 | CSNK1D | 0.38551729 |
| 125 | TNK2 | 0.38352710 |
| 126 | MKNK1 | 0.37360537 |
| 127 | CSNK1E | 0.37040245 |
| 128 | ERBB2 | 0.36838923 |
| 129 | ADRBK1 | 0.36042870 |
| 130 | LIMK1 | 0.35579530 |
| 131 | MAPK8 | 0.35000633 |
| 132 | PRKCA | 0.34582212 |
| 133 | MAP2K1 | 0.33898396 |
| 134 | YES1 | 0.33379917 |
| 135 | RPS6KA4 | 0.32926370 |
| 136 | TXK | 0.31310432 |
| 137 | LATS1 | 0.29109235 |
| 138 | PRKACB | 0.28738875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.68833777 |
| 2 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.07795211 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.01609933 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.94614566 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.83769304 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.81667012 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.80177596 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.69948376 |
| 9 | Taste transduction_Homo sapiens_hsa04742 | 2.47440849 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.31554052 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.31323625 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.25930826 |
| 13 | Long-term depression_Homo sapiens_hsa04730 | 2.11312394 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10100959 |
| 15 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.94619266 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.91041138 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.89757680 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.81915198 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80835233 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80067909 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.77446680 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75517528 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.73221985 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.58700486 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56540546 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53684486 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51675058 |
| 28 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44681819 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37923780 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.34174187 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.33115623 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.33031804 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.32333471 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.31806785 |
| 35 | Axon guidance_Homo sapiens_hsa04360 | 1.29012452 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.28527708 |
| 37 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26341478 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25650025 |
| 39 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23698856 |
| 40 | * Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.22960223 |
| 41 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.22741072 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.22263668 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16432543 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 1.15012781 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.13708722 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.12272198 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09103582 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06388273 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05491781 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.04171971 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.01958173 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.98841790 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.98518849 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.95722688 |
| 55 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92248320 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89844084 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89709786 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89586079 |
| 59 | Protein export_Homo sapiens_hsa03060 | 0.88038203 |
| 60 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86748000 |
| 61 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86593215 |
| 62 | Glioma_Homo sapiens_hsa05214 | 0.85980224 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85393844 |
| 64 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.83308442 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80015277 |
| 66 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78387261 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.77954400 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76551591 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76440990 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75626029 |
| 71 | Huntingtons disease_Homo sapiens_hsa05016 | 0.74568939 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74276233 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.72985478 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72620147 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71198769 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71160396 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71075434 |
| 78 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70043225 |
| 79 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.67261342 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64677920 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62210915 |
| 82 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62189454 |
| 83 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62071680 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.61676872 |
| 85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61082761 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60702896 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60408580 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59604143 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58314463 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56526702 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53066520 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52148208 |
| 93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52116052 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.52053897 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51487818 |
| 96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50524143 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.49982508 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49965814 |
| 99 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48317021 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47001396 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46384598 |
| 102 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46377055 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45083354 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.44602912 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44327467 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.43668103 |
| 107 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43465505 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43367769 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42617736 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42144045 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40794968 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.38720929 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37253990 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.37243978 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.36650970 |
| 116 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.36275090 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.35429517 |
| 118 | Alcoholism_Homo sapiens_hsa05034 | 0.35404907 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.34627930 |
| 120 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34156241 |
| 121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32206474 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31488271 |
| 123 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.30929439 |
| 124 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.30451352 |
| 125 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27781510 |
| 126 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.27512770 |
| 127 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.26896278 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.26277095 |
| 129 | Melanoma_Homo sapiens_hsa05218 | 0.25188213 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.22192390 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.20837166 |
| 132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20244981 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.18826803 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18350080 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.18010743 |

